Genentech Avastin Line At Vacaville Facility Gains FDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Product produced at the Vacaville, Calif. site will start shipping by September, Genentech says. The South San Francisco facility will continue to manufacture Avastin.